These results demonstrated DEXP&A2&N-mediated targeted recruitment and activation of DCs, particularly cross-presenting CD103+CD11c+ DCs to tumor sites in orthotopic HCC mice. This evidence concerns the gene ITGAX and hepatocellular carcinoma.